Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Real-Time PCR Of Oropharyngeal Swabs Diagnoses Pneumonia in Adults

By LabMedica International staff writers
Posted on 13 Dec 2016
A lack of sensitive tests and difficulties obtaining representative samples contribute to the challenge in identifying etiology in pneumonia. More...
Upper respiratory tract swabs can be easily collected and analyzed with real-time polymerase chain reaction (rtPCR).

The microbial etiology of pneumonia often remains undetected despite extensive diagnostic testing. Blood cultures lack sensitivity and obtaining representative lower respiratory tract samples can be challenging. An etiologic diagnosis allows targeted antimicrobial treatment, a matter of increasing importance as resistance rates increase.

Medical scientists at the University of Iceland (Reykjavik, Iceland) prospectively collected oropharyngeal swabs from 239 adults admitted to hospital with pneumonia. Blood cultures were collected, incubated and cultured using standard methods. Urine antigen testing (UAT) for Streptococcus pneumoniae (SP) was performed using a commercially available kit, the BinaxNOW Streptococcus pneumoniae (Alere, Waltham, MA, USA). An oropharyngeal swab sample using sterile rayon tipped swabs, (COPAN Italia, Brescia, Italy) was collected for rtPCR.

The team extracted nucleic acid from 200 μL specimens and rtPCR was performed with an ABI 7900 384-well system (Applied Biosystems, Foster City, CA, USA). The specificity of rtPCR for SP and Haemophilus influenzae (HI) was tested using reference samples containing S. mitis, S. oralis and S. sanguinis, and H. haemolyticus and H. parainfluenzae respectively. No cross-reaction was noted with either comparison. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of rtPCR for SP and HI were calculated using combined and separate results from sputum (SP and HI) and blood cultures (SP only), and urine antigen analysis (SP only) as a reference “gold standard”.

When the investigators compared the rtPCR with conventional testing for S. pneumoniae in 57 patients with all tests available, this resulted in a sensitivity of 87 %,a specificity of 79 %, PPV equalled 59 % and the NPV was 94 %, and for 67 H. influenzae patients, the sensitivity was, 75 %, specificity 80 %, PPV 45 % and NPV 94 %. When patients with prior antimicrobial exposure were excluded sensitivity improved: 92 % for S. pneumoniae and 80 % for H. influenzae. Receiver operating characteristic curve analysis demonstrated for S. pneumoniae: AUC = 0.65 and for H. influenzae: AUC = 0.86. Using rtPCR SP was identified in 61 (25.5 %) cases and HI in 50 (20.9 %).

The authors concluded that analysis of oropharyngeal swabs using rtPCR proved both reasonably sensitive and specific for diagnosing pneumonia caused by S. pneumoniae and H. influenzae. This method may be a useful diagnostic adjunct to other methods and of special value in patients unable to provide representative lower airway samples. The study was published online on November 7, 2016, in the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:
University of Iceland
Alere
COPAN Italia
Applied Biosystems

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.